Valuation: Ginwa Enterprise (Group) Inc.

Market Cap 1.68B 248M 216M 200M 185M 348M 23.7B 354M 2.37B 928M 11.77B 932M 912M 39.58B P/E 2024
37.4x
P/E 2025 171x
Enterprise Value 1.32B 196M 170M 158M 146M 275M 18.7B 279M 1.87B 733M 9.29B 736M 720M 31.24B EV / Sales 2024
4.15x
EV / Sales 2025 4.24x
Free-Float
66.46%
Yield 2024
0.38%
Yield 2025 0.4%
1 day-1.24%
1 week+5.78%
Current month+6.49%
1 month+5.08%
3 months-40.65%
6 months-39.36%
Current year-36.87%
1 week 4.46
Extreme 4.46
4.9
1 month 4.38
Extreme 4.38
5.18
Current year 4.26
Extreme 4.26
9.3
1 year 4.26
Extreme 4.26
9.35
3 years 4.26
Extreme 4.26
9.35
5 years 4.26
Extreme 4.26
10.97
10 years 3.7
Extreme 3.7
14.93
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-28
Director of Finance/CFO 44 2025-04-09
Corporate Officer/Principal 30 2022-02-15
Director TitleAgeSince
Director/Board Member 63 2011-04-20
Chairman 55 2020-06-28
Chairman 59 2022-02-21
Change 5-day change 1-year change 3-year change Capi.($)
-1.24%+5.78%-38.02%-37.29% 251M
-4.55%-2.61%+51.95%+151.91% 1,079B
-3.66%-1.33%+52.95%+46.62% 640B
-2.24%+0.19%+35.97%+70.64% 465B
-2.29%+1.12%+36.13%+31.18% 353B
-2.28%-0.69%+33.42%+40.48% 301B
-3.15%+0.25%+10.63%+15.03% 271B
-2.12%+3.31%+1.82%-37.38% 228B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 165B
Average -1.77%+4.83%+22.79%+41.60% 370.99B
Weighted average by Cap. -1.62%+4.86%+38.04%+72.88%

Financials

2024 2025
Net sales 585M 86.57M 75.19M 69.83M 64.4M 121M 8.26B 124M 827M 324M 4.1B 325M 318M 13.8B 544M 80.45M 69.87M 64.89M 59.84M 113M 7.68B 115M 768M 301M 3.81B 302M 295M 12.83B
Net income 74.61M 11.03M 9.58M 8.9M 8.21M 15.46M 1.05B 15.74M 105M 41.25M 523M 41.43M 40.52M 1.76B 15.58M 2.3M 2M 1.86M 1.71M 3.23M 220M 3.29M 21.99M 8.61M 109M 8.65M 8.46M 367M
Net Debt -327M -48.28M -41.94M -38.94M -35.91M -67.65M -4.61B -68.88M -461M -181M -2.29B -181M -177M -7.7B -354M -52.34M -45.46M -42.22M -38.93M -73.34M -5B -74.67M -500M -196M -2.48B -197M -192M -8.35B
Logo Ginwa Enterprise (Group) Inc.
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Employees
613
Date Price Change Volume
26-07-30 CN¥4.760 -1.24% 1,851,100
26-07-29 CN¥4.820 +1.26% 2,506,100
26-07-28 CN¥4.760 +1.71% 1,542,400
26-07-27 CN¥4.680 +3.08% 2,213,600
26-07-24 CN¥4.540 -1.94% 2,227,500
  1. Stock Market
  2. Stocks
  3. 600080 Stock